STAT | Reporting from the frontiers of health and medicine 中文 关注 STAT+：Pharmalittle：我们正阅读关于一种罕见病药物、制药公司向医生支付款项等方面的担忧，以及更多内容” 患者倡导者及部分专家对诺诚健华（Neurocrine Biosciences）一款罕见病药物所存在的潜在风险日益表示担忧。 STAT+: Pharmalittle: We’re reading about concerns over a rare disease drug, pharma payments to docs, and more statnews.com STAT | Reporting from the frontiers of health and medicine 中文 RSS thenote.app
